SPIROMETRY VERSUS AIRWAVE OSCILLOMETRY FOR ASSESSMENT OF MEPOLIZUMAB EFFICACY IN SEVERE EOSINOPHILIC ASTHMA

被引：0
|
作者：
Yang, J. F. [1 ]
Pavord, I. D. [2 ]
Heaney, L. G. [3 ]
Brightling, C. E. [4 ]
Borg, K. [2 ]
Busby, J. [3 ]
Grandison, T. [5 ]
Smith, S. J. [5 ]
Lee, W. N. [5 ]
Shepherd, M. [1 ]
Chaudhuri, R. [1 ]
机构：
[1] Univ Glasgow, Glasgow, Lanark, Scotland
[2] Univ Oxford, Oxford, England
[3] Queen, Belfast, Antrim, North Ireland
[4] Univ Leicester, Leicester, Leics, England
[5] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland
来源：
THORAX | 2021年 / 76卷
关键词：
D O I：
10.1136/thorax-2020-BTSabstracts.247
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P102
引用
收藏
页码：A142 / A143
页数：2
相关论文
共 50 条
  • [41] CLINICAL RESPONSE TO MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Harvey, E.
    Langton, D.
    Powell, H.
    Gibson, P.
    RESPIROLOGY, 2019, 24 : 42 - 42
  • [42] Secondary loss of response to mepolizumab in severe eosinophilic asthma
    Cormier, Maxime
    Chaboillez, Simone
    Lemiere, Catherine
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 736 - 738
  • [43] Efficacy of oral prednisolone in patients with stable severe eosinophilic asthma (SEA) treated with Mepolizumab
    Yang, Jieqiong
    Busby, John
    Heaney, Liam G.
    Brightling, Chris E.
    Pavord, Ian D.
    Borg, Katie
    Mcdowell, Pamela Jane
    Diver, Sarah
    Shrimanker, Rahul
    Smith, Steven
    Shepherd, Malcolm
    Lee, Waiting Nicola
    Chaudhuri, Rekha
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [44] GREATER EFFICACY OF MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA WITH HIGH BASELINE BLOOD EOSINOPHIL COUNTS
    Silver, J.
    Llanos, J.
    Mayer, B.
    Prazma, C.
    Albers, F.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (05) : S37 - S38
  • [45] Clinical response to mepolizumab in patients with severe eosinophilic asthma
    Harvey, Erin
    Langton, David L.
    Powell, Heather
    Gibson, Peter G.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [46] Impact of Mepolizumab on Airway Remodelling in Severe Eosinophilic Asthma
    Taille, C.
    Hamidi, F.
    Heddebaut, N.
    Dupin, C.
    Le Guen, P.
    Le Brun, M.
    Pote, N.
    Cazes, A.
    Roy, C.
    Dupont, A.
    Letuve, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [47] Efficacy and Safety of Mepolizumab in a Real-World Cohort of Patients with Severe Eosinophilic Asthma
    Pertzov, B.
    Unterman, A.
    Shtraichman, O.
    Shitenberg, D.
    Rosengarten, D.
    Kramer, M. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [48] Efficacy and safety of mepolizumab in a real-world cohort of patients with severe eosinophilic asthma
    Pertzov, Barak
    Avraham, Unterman
    Osnat, Shtraichman
    Dorit, Shitenberg
    Dror, Rosengarten
    Reuven, Kramer Mordechai
    JOURNAL OF ASTHMA, 2021, 58 (01) : 79 - 84
  • [49] Phenotyping Mepolizumab EXacerbations in severe eosinophilic asthma (MEX)
    McDowell, Pamela Jane
    Diver, Sarah
    Yang, Jieqiong Freda
    Borg, Catherine
    Busby, John
    Brown, Vanessa
    Shrimanker, Rahul
    Cox, Ciara
    Brightling, Christopher
    Chaudhuri, Rekha
    Pavord, Ian
    Heaney, Liam
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [50] Continued long-term mepolizumab in severe eosinophilic asthma protects from asthma worsening versus stopping mepolizumab: COMET trial
    Bel, Elisabeth H. D.
    Moore, Wendy C.
    Kornmann, Oliver
    Poirier, Claude
    Kaneko, Nirihiro
    Smith, Steven G.
    Martin, Neil
    Gilson, Martyn J.
    Price, Robert G.
    Bradford, Eric S.
    Humbert, Marc
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
12345